ライフサイエンスコーパス: postresection

1 N primary because they were apparently cured postresection.

2 t in patients displaying hepatic dysfunction postresection.

3 ning by FDG-PET is associated with excellent postresection 5-year overall survival for patients under

4 at western and eastern centers vary widely, postresection 5-year survival is similar when controllin

5 Postresection adaptation involves parallel changes in cr

6 death was the same across all sites 3 years postresection and decreased significantly for extremity/

7 study, disease-free patients at least 1 year postresection and gastric conduit reconstruction receive

8 %) showed early recurrence (within 12 months postresection) and 42 (54.5%) showed late recurrence.

9 ophagectomy (ES), n = 10, 2.4 +/- 0.75 years postresection; and unoperated control subjects, n = 8] w

10 extremity/trunk STS decreased by 40% 3 years postresection, but their influence over DSS for non-extr

11 tumor-catheter was resected en bloc, and the postresection cavity was treated with Ad-p53.

12 To identify new treatments we focused on postresection changes in microRNAs--short noncoding RNAs

13 ied how HFOs and spikes in combined pre- and postresection ECoG predict surgical outcome in different

14 ripples (80-250 Hz), and spikes in pre- and postresection ECoG sampled at 2,048 Hz in people with re

15 been used in patients who have a predicted (postresection) future liver remnant (FLR) volume less th

16 CA19-9 >/= 1,000 U/mL that does not decrease postresection have the worst prognosis, but the mechanis

17 HAF) were measured intraoperatively pre- and postresection in 67 consecutive patients with major hepa

18 For participants with postresection local recurrence, the median OS was 16 mon

19 n the diagnostic evaluation of cysts and the postresection management of mucinous lesions.

20 Postresection, mean ex vivo radionuclide counts were hig

21 c colorectal carcinoma in the liver and that postresection MMP9 inhibition may be clinically benefici

22 resection predictive factors were absence of postresection morbidity, and T-stage 1-2 at the resectio

23 Postresection MR images were coregistered to the SPECT s

24 urrence patterns and treatment of recurrence postresection of adenocarcinoma arising from IPMN are po

25 f locally recurrent rectal cancer (LRRC) and postresection oncologic outcomes of LRRC.

26 f the present study was to compare long-term postresection oncological outcomes between adenocarcinom

27 Using a postresection pancreatic adenocarcinoma nomogram, patien

28 ed the determinants of long-term survival in postresection pancreatic cancer patients, but the majori

29 ical model to long-term follow-up studies of postresection patients to investigate the factors involv

30 After a median postresection period of 44 months, recurrence was observ

31 Additional postresection predictive factors were absence of postres

32 pancreatectomy for PNETs and to establish a postresection prognostic score.

33 f survival and were incorporated into a PNET postresection prognostic score.

34 middle hepatic vein resection caused higher postresection PVP after right hepatectomy (P = 0.04), th

35 aoperative dynamics rather than the pre- and postresection PVP values.

36 ion, with the "safety net" of SLT in case of postresection recurrence.

37 Improved education on postresection risk assessment and risk reduction is need

38 r <1.5 mm was an independent determinants of postresection survival in certain subgroups.

39 re rare pancreatic neoplasms associated with postresection survival longer than ductal adenocarcinoma

40 MA-score, based on independent predictors of postresection survival, including pathologic variables a

41 lesions in the pancreatic head, have similar postresection survival.

42 ains an important independent determinant of postresection survival.

43 Postresection, the expression of caspases and genes invo

44 By 1-week postresection, villus heights and crypt depths were incr

45 nant liver volume in patients with estimated postresection volumes of less than 25% appears to reduce

46 fresh-frozen plasma after the first 24 hours postresection) was higher in the non-PVE patients than t

47 between 1 and 5 micrometastases at 10 years postresection, when they escape growth restriction with

48 t approach - perioperative therapy, adjuvant postresection with either systemic or hepatic arterial i

49 Postresection wound bed fluorescence was significantly l